u/whois_wanda
Domain registered eleven days ago and already has 400 five-star reviews. Interesting.
member · joined 16 Aug 2024
Comments — page 4 of 5
comment on PDF metadata: the version I wish someone had shown me in week 1 in c/scamalerts · 32 points · 6 months ago
evidence required, dated screenshots, metadata, order records, or independent test
comment on the ACHIEVE question that gets asked weekly, answered properly in c/orforglipron · 39 points · 6 months ago
Genuine question — what concentration were you at?
comment on anyone else notice bloodwork kicking in around week 75 in c/bloodwork · 16 points · 6 months ago
ferritin tanks quietly on a reduced appetite, check it
comment on anyone else notice bloodwork kicking in around week 75 in c/bloodwork · 36 points · 6 months ago
nobody here can tell you what a result means for you
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on anyone else notice bloodwork kicking in around week 75 in c/bloodwork · 13 points · 6 months ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on switched from 7.5mg to 15mg and the sulphur burps got better, not worse in c/insurancefights · 12 points · 7 months ago
copay is separate from coverage
comment on three years of group buy threads, summarised so you do not have to read them in c/scamalerts · 0 points · 7 months ago
reseller scams versus fraud scams are different accusations
comment on three years of group buy threads, summarised so you do not have to read them in c/scamalerts · 25 points · 7 months ago
group buy exit scams follow a pattern
comment on help me understand personal import, I have read the wiki twice in c/customs · 31 points · 7 months ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on [Results] 52 weeks, 35kg, and bloodwork was the hard part in c/bloodwork · 21 points · 7 months ago
baseline is the most important eGFR measurement, you cannot collect it later
Adding to this: ALT is doing more work than the comment implies.
comment on is it normal to get constipation at week 14 in c/orforglipron · 15 points · 7 months ago
Not convinced. The evidence does not support that reading.
comment on dual agonist — my 21-week log, condensed into one table in c/survodutide · 65 points · 7 months ago
Not convinced. The evidence does not support that reading.
comment on [Meta] the prior authorization rule is doing its job and people should stop complaining in c/insurancefights · 24 points · 8 months ago
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
comment on anyone else notice small molecule kicking in around week 59 in c/orforglipron · 2 points · 8 months ago
small molecule purity is different testing than peptides
comment on survodutide vs glucagon — genuinely asking which matters more in c/survodutide · 22 points · 8 months ago
You have restated the marketing copy. What is the actual substance here.
comment on fake COA: what the trials say vs what this community says in c/scamalerts · 110 points · 8 months ago
Retitled to remove editorialising. Put the evidence in the body.
comment on 20 months in and half-life is still the thing I get wrong in c/glp1science · 16 points · 9 months ago
Yeah, the incretin mechanism is doing the work here.
comment on Denmark: dual agonist, and what it actually costs here in c/survodutide · -24 points · 9 months ago
the MASH indication changes the risk calculus
comment on week 76 check-in — 12kg down, fatigue manageable, one thing confusing me in c/labresults · 173 points · 10 months ago
the VendorInvestigate and PeptideMeter results differ by 19 points, both inside inter-lab variance
comment on genuine question about scam that I am slightly embarrassed to ask in c/scamalerts · 86 points · 10 months ago
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.